.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cipla
McKesson
Medtronic
Boehringer Ingelheim
US Army
Fuji
Merck
Farmers Insurance
Cantor Fitzgerald

Generated: December 15, 2017

DrugPatentWatch Database Preview

DECADRON Drug Profile

« Back to Dashboard

When do Decadron patents expire, and when can generic versions of Decadron launch?

Decadron is a drug marketed by Merck and is included in eight NDAs.

The generic ingredient in DECADRON is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
MerckDECADRONdexamethasone sodium phosphateCREAM;TOPICAL011983-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasoneTABLET;ORAL011664-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasone sodium phosphateINJECTABLE;INJECTION012071-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasoneTABLET;ORAL011664-006Jul 30, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasoneTABLET;ORAL011664-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
MerckDECADRON-LAdexamethasone acetateINJECTABLE;INJECTION016675-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasoneELIXIR;ORAL012376-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasone sodium phosphateINJECTABLE;INJECTION012071-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasone sodium phosphateSOLUTION/DROPS;OPHTHALMIC, OTIC011984-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckDECADRONdexamethasone sodium phosphateOINTMENT;OPHTHALMIC011977-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Novartis
Covington
Julphar
Deloitte
Harvard Business School
Queensland Health
Chubb
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot